Biotech news
Biotech
An alliance of companies that use gene-editing technologies has released a bioethical framework, as controversy over gene-editing continues. 3 September 2019
Pharma
Nicole Jadeja, the former co-head of life sciences at Fieldfisher, has joined Pinsent Masons as a partner in its London office. 3 September 2019
Biotech
For all the importance of the role of government and private sector bodies in the realisation of precision medicine, it’s important not to lose sight of the interests and concerns of those precision medicine intends to treat—the patients and public at large, write Daniel Lim and Anna Jackson of Kirkland & Ellis. 29 August 2019
Pharma
Biotech company Ionis Pharmaceuticals is to license its antisense medicines, used to treat people with chronic hepatitis B, to GlaxoSmithKline. 28 August 2019
Americas
Ireland-based Jazz Pharma has acquired Virginia-based Cavion in a deal that values the clinical-stage biotech company at up to $312.5 million. 14 August 2019
Americas
Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion. 9 August 2019
Pharma
The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced. 8 August 2019
Biotech
In future, the more efficient targeting of treatments to specific patient populations that will actually benefit from them, could offset the price of more expensive but well targeted and effective treatments that will be suitable for increasingly smaller patient populations. Daniel Lim and Anna Jackson of Kirkland & Ellis explain. 8 August 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, August 6, affirmed a US International Trade Commission decision to uphold a patent related to E. coli bacteria. 7 August 2019
Biotech
Exact Sciences will acquire Genomic Health in a merger deal worth $2.8 billion. 31 July 2019